Cerenkov Luminescence Imaging at a Glance

Cerenkov luminescence imaging (CLI) is a new technique that has rapidly gained great interest in the molecular imaging field bridging optical imaging and nuclear medicine. Based on the detection of Cerenkov radiation (CR) in biological tissue, in only five years many different applications of CLI were developed spanning from cancer imaging to Alzheimer's disease and many different approaches were tested in order to increase its potentialities. In particular some efforts were made to transform CLI from a planar imaging technique into a tomographic technique or to shift the CR in a red-infrared radiation more suitable for biological applications. Moreover CLI, developed as a preclinical investigation, has obtained very quickly, interesting results on humans. Here we present a schematic and brief overview of the CLI landscape in order to show the principal results and applications to the biology. More precisely we focused on the potentialities of optical detection of ra- diotracers excluding the application of Cerenkov radiation obtained with the use of external radiation beam. Cerenkov luminescence imaging (CLI) has been recently introduced in the Optical Imaging (OI) landscape as a new pre-clinical imaging tool to investigate much pathology in vivo. It is based on the detection of light produced by high energy charged particle (like electron or positron) moving faster than the speed of light in a dielectric medium. When travelling in the medium the particle can polarize the sur- rounding molecules and, when they relax back, they can emit light in the form of radiation luminescence. This is the so- called Cerenkov radiation (CR). It occurs if the energy of the particle is greater than a threshold that is around 220 keV in biological tissues. The CR spectrum consists of continuous wavelengths throughout the ultraviolet, visible and near in- frared range. The intensity distribution is inversely propor- tional to the square of the wavelength. The emitted photons can be detected by a variety of light sensitive detectors, like photomultipliers, highly sensitive charge-coupled device (CCD), and others. CR was discovered by Pavel Alek- seyevich Cerenkov in 1932 and the theoretical analysis of the experimental data was provided by Frank and Tamm in 1937 (1). Due to faint emission the detection in biological tissues was very challenging. A very preliminary attempt was made by Burch in 1971 (2); he detected CR in human eye tumors treated with 32P with a photomultiplier tube, but this method was not employed subsequently and no imaging was performed. For a real imaging of CR emitted by tissues we had to wait for about 40 years. Now different applica- tions of CLI were developed and many efforts were done in order to increase the potentialities of the technique. In this review our goal was to present almost all the studies referred to CLI in biomedical field and we tried to organize them in one table (Table 1) for a fast consultation. In the table the

[1]  John L. Humm,et al.  Quantitative Modeling of Cerenkov Light Production Efficiency from Medical Radionuclides , 2012, PloS one.

[2]  Lei Xing,et al.  Synthesis and Radioluminescence of PEGylated Eu3+‐doped Nanophosphors as Bioimaging Probes , 2011, Advanced materials.

[3]  Jan Grimm,et al.  Clinical Cerenkov Luminescence Imaging of 18F-FDG , 2014, The Journal of Nuclear Medicine.

[4]  Riccardo Calandrino,et al.  Optical imaging of alpha emitters: simulations, phantom, and in vivo results. , 2011, Journal of biomedical optics.

[5]  Xing Zhang,et al.  Cerenkov Luminescence Tomography for In Vivo Radiopharmaceutical Imaging , 2011, Int. J. Biomed. Imaging.

[6]  F. Boschi,et al.  Imaging of luminescence induced by beta and gamma emitters in conventional non-scintillating materials , 2014 .

[7]  Jie Tian,et al.  Cerenkov Luminescence Tomography of Aminopeptidase N (APN/CD13) Expression in Mice Bearing HT1080 Tumors , 2013, Molecular imaging.

[8]  Federico Boschi,et al.  Optimizing in vivo small animal Cerenkov luminescence imaging. , 2012, Journal of biomedical optics.

[9]  Jan Grimm,et al.  Cerenkov Luminescence Imaging of Medical Isotopes , 2010, Journal of Nuclear Medicine.

[10]  S R Cherry,et al.  Optical imaging of Cerenkov light generation from positron-emitting radiotracers , 2009, Physics in medicine and biology.

[11]  Jan Grimm,et al.  Positron Lymphography: Multimodal, High-Resolution, Dynamic Mapping and Resection of Lymph Nodes After Intradermal Injection of 18F-FDG , 2012, The Journal of Nuclear Medicine.

[12]  Lei Xing,et al.  Intraoperative Imaging of Tumors Using Cerenkov Luminescence Endoscopy: A Feasibility Experimental Study , 2012, The Journal of Nuclear Medicine.

[13]  Jan Grimm,et al.  Intraoperative Imaging of Positron Emission Tomographic Radiotracers Using Cerenkov Luminescence Emissions , 2011, Molecular imaging.

[14]  S. Brown,et al.  Cerenkov radiation and its applications , 1955 .

[15]  Lei Xing,et al.  Radioluminescent nanophosphors enable multiplexed small-animal imaging , 2012, Optics express.

[16]  Jie Tian,et al.  Experimental Cerenkov luminescence tomography of the mouse model with SPECT imaging validation. , 2010, Optics express.

[17]  R Calandrino,et al.  Optical imaging of radioisotopes: a novel multimodal approach to molecular imaging. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[18]  Younan Xia,et al.  Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. , 2013, Nano letters.

[19]  Simon R Cherry,et al.  Cerenkov luminescence tomography for small-animal imaging. , 2010, Optics letters.

[20]  Matthew D Silva,et al.  Multimodal Imaging with 18F-FDG PET and Cerenkov Luminescence Imaging After MLN4924 Treatment in a Human Lymphoma Xenograft Model , 2011, The Journal of Nuclear Medicine.

[21]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Zhen Cheng,et al.  Optical imaging of reporter gene expression using a positron-emission-tomography probe. , 2010, Journal of biomedical optics.

[23]  Andrea Sbarbati,et al.  Cerenkov radiation allows in vivo optical imaging of positron emitting radiotracers , 2010, Physics in medicine and biology.

[24]  Riccardo Calandrino,et al.  In vivo 18F-FDG tumour uptake measurements in small animals using Cerenkov radiation , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  Zhen Cheng,et al.  Endoscopic imaging of Cerenkov luminescence , 2012, Biomedical optics express.

[26]  Y. Nie,et al.  Targeted radiotherapy with tumor vascular homing trimeric GEBP11 peptide evaluated by multimodality imaging for gastric cancer. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Vikram D Kodibagkar,et al.  On the potential for molecular imaging with Cerenkov luminescence. , 2010, Optics letters.

[28]  Anna Moore,et al.  In Vivo Photoactivation Without “Light”: Use of Cherenkov Radiation to Overcome the Penetration Limit of Light , 2011, Molecular Imaging and Biology.

[29]  Jan Grimm,et al.  Quantitative imaging of disease signatures through radioactive decay signal conversion , 2013, Nature Medicine.

[30]  Riccardo Calandrino,et al.  Multispectral Cerenkov luminescence tomography for small animal optical imaging. , 2011, Optics express.

[31]  Jie Tian,et al.  Fast-Specific Tomography Imaging via Cerenkov Emission , 2012, Molecular Imaging and Biology.

[32]  Kyung-Han Lee,et al.  Binding of 2-[18F]fluoro-CP-118,954 to mouse acetylcholinesterase: microPET and ex vivo Cerenkov luminescence imaging studies. , 2011, Nuclear medicine and biology.

[33]  Johan Axelsson,et al.  (68)Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes. , 2013, American journal of nuclear medicine and molecular imaging.

[34]  Carlo Cavedon,et al.  First human Cerenkography , 2013, Journal of biomedical optics.

[35]  Jimin Liang,et al.  Three-dimensional Noninvasive Monitoring Iodine-131 Uptake in the Thyroid Using a Modified Cerenkov Luminescence Tomography Approach , 2012, PloS one.

[36]  C. Kuo,et al.  In Vivo Optical Imaging of Interscapular Brown Adipose Tissue with 18F-FDG via Cerenkov Luminescence Imaging , 2013, PloS one.

[37]  Erin Jackson,et al.  Cerenkov Radiation Energy Transfer (CRET) Imaging: A Novel Method for Optical Imaging of PET Isotopes in Biological Systems , 2010, PloS one.

[38]  Riccardo Calandrino,et al.  Optical imaging of Tc-99m-based tracers: in vitro and in vivo results. , 2011, Journal of biomedical optics.

[39]  Barbara Rossi,et al.  Small-animal radionuclide luminescence imaging of thyroid and salivary glands with Tc99m-pertechnetate , 2013, Journal of biomedical optics.

[40]  S. Cherry,et al.  New covalent capture probes for imaging and therapy, based on a combination of binding affinity and disulfide bond formation. , 2011, Bioconjugate chemistry.

[41]  Federico Boschi,et al.  Unsupervised analysis of small animal dynamic Cerenkov luminescence imaging. , 2011, Journal of biomedical optics.

[42]  Jie Tian,et al.  Single photon emission computed tomography-guided Cerenkov luminescence tomography , 2012 .

[43]  R. Weissleder Molecular Imaging in Cancer , 2006, Science.

[44]  Federico Boschi,et al.  Quantum dots excitation using pure beta minus radioisotopes emitting Cerenkov radiation , 2012 .

[45]  Byeong-Cheol Ahn,et al.  Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: initial feasibility study. , 2011, Endocrine journal.

[46]  Zhe Wang,et al.  Enhancement of Cerenkov Luminescence Imaging by Dual Excitation of Er3+, Yb3+-Doped Rare-Earth Microparticles , 2013, PloS one.

[47]  Zhen Cheng,et al.  Evaluation of 89Zr-rituximab Tracer by Cerenkov Luminescence Imaging and Correlation with PET in a Humanized Transgenic Mouse Model to Image NHL , 2013, Molecular Imaging and Biology.

[48]  Se-Il Park,et al.  Luminescence imaging using radionuclides: a potential application in molecular imaging. , 2011, Nuclear medicine and biology.

[49]  Zhen Cheng,et al.  Proof-of-Concept Study of Monitoring Cancer Drug Therapy with Cerenkov Luminescence Imaging , 2012, The Journal of Nuclear Medicine.

[50]  Jie Tian,et al.  Whole-Body Cerenkov Luminescence Tomography with the Finite Element SP3 Method , 2011, Annals of Biomedical Engineering.

[51]  Zhen Cheng,et al.  Radiation-luminescence-excited quantum dots for in vivo multiplexed optical imaging. , 2010, Small.

[52]  Yeong Su Ha,et al.  Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging. , 2010, Small.

[53]  Burch Wm Cerenkov light from 32 P as an aid to diagnosis of eye tumours. , 1971 .

[54]  A. Wolf,et al.  Synthesis of carbon-11, fluorine-18, and nitrogen-13 labeled radiotracers for biomedical applications. Nuclear Science Series: Nuclear Medicine , 1982 .

[55]  Sanjiv S. Gambhir,et al.  Molecular Optical Imaging with Radioactive Probes , 2010, PloS one.